-
Under scrutiny for Cohen deal, Novartis calls off further price hikes in 2018
fiercepharma
July 19, 2018
Even before Pfizer faced the wrath of U.S. President Donald Trump for July price hikes, Novartis decided against putting through more of its own increases in 2018, its helmsman told analysts on Wednesday.
-
Winning Trump’s praise was easy for Pfizer. Wall Street and the Hill? Not so much
fiercepharma
July 18, 2018
When President Donald Trump praised Pfizer on Twitter for delaying price hikes on 40 of its drugs last week
-
Trump slams Pfizer over price hikes, Pfizer responds
pharmafile
July 17, 2018
Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks to in part to Donald Trump’s sporadic highlighting of the issue leading up to and throughout his presidency.
-
Trump forces Pfizer to back down and delay price hikes until 2019
pharmafile
July 17, 2018
Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the President’s threats to crack down on drug prices and raised the price of 100 of its drugs, the firm has confirmed it will delay planned price hi
-
Senate claims Novartis misled public on Trump lawyer deal
pharmafile
July 17, 2018
A report released by the United States Senate has found that Novartis’ relationship with Donald Trump’s long-time lawyer Michael Cohen “was longer and more detailed than previously disclosed by the company” and that Novartis “explicitly sought to hire Mic
-
Unfazed by Trump, Pfizer hikes prices for 100 of its drugs
pharmafile
July 06, 2018
Undeterred by these proposals, a number of pharma firms have proceeded to simply ignore the lacklustre plans and raise their prices anyway.
-
Trump’s trade war with China could drive up US pharma costs
pharmaphorum
April 16, 2018
New tariffs on goods coming from China could hit the US pharmaceutical industry, according to a new analysis – and even undermine President Trump’s pledge to drive down the price of medicines.
-
Trump's latest pick for a top healthcare post, CDC Director Robert Redfield, touts importance of vaccination
fiercepharma
April 09, 2018
Vaccine skeptics have voiced frustration over an apparent change of heart by President Donald Trump on vaccine safety, but ...
-
What Trump should do if he actually wants to cut drug prices
newsday
November 27, 2017
President Donald Trump nominated Alex Azar to serve the next secretary of health and human services last week, tweeting that he would be “a star for better healthcare and lower drug prices!”
-
Trump nominates ex-drug company executive as new health secretary
theguardian
November 14, 2017
US president nominates Alex Azar, who worked for a decade in the pharmaceutical industry, prompting outcry over ‘big pharma in US Congress’